- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
LERONLIMAB (Twitter) - May 12, 2020
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
#leronlimab (Twitter) - May 6, 2020
- |||||||||| leronlimab (PRO 140) / CytoDyn, Vyera Pharma
LERONLIMAB (Twitter) - Apr 27, 2020
- |||||||||| carboplatin / Generic mfg., Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
[VIRTUAL] Phase Ib/II study of leronlimab (PRO 140) combined with carboplatin in CCR5+ mTNBC patients (Virtual Meeting: All Session Times Are U.S. EDT) - Apr 13, 2020 - Abstract #AACRI2020AACR-I_414; Leronlimab (PRO 140), a CCR5 antagonist mAb, in combination with carboplatin is currently enrolling newly diagnosed mTNBC. The preliminary analysis shows safety and tolerability of the combination and continue to enroll patients with initial promising clinical activity, potentially suggesting the future availability of a new effective agent in the management of this serious condition.
|